Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Summary<br/> <strong>Background:</strong> The ICON7 trial previously reported improved progression-free survival in women with ovarian cancer with the addition of bevacizumab to standard chemotherapy, with the greatest effect in patients at high risk of disease progression. We rep...

书目详细资料
Main Authors:	Oza, A, Cook, A, Pfisterer, J, Embleton, A, Ledermann, J, Pujade-Lauraine, E, Kristensen, G, Carey, M, Beale, P, Cervantes, A, Park-Simon, T, Rustin, G, Joly, F, Mirza, M, Plante, M, Quinn, M, Poveda, A, Jayson, G, Stark, D, Swart, A, Farrelly, L, Kaplan, R, Parmar, M, Perren, T
格式:	Journal article
出版:	Elsevier 2015

相似书籍

Quality of life of weekly, dose-dense versus standard chemotherapy for ovarian cancer in the ICON8 study
由: Blagden, S, et al.
出版: (2017)

A phase I study of combretastatin A4 phosphate (CA4P) and bevacizumab in subjects with advanced solid tumors
由: Nathan, P, et al.
出版: (2008)

ICON ComIn – the ICON Community Interface (ComIn version 0.1.0, with ICON version 2024.01-01)
由: K. Hartung, et al.
出版: (2025-02-01)

Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumab.
由: Koukourakis, M, et al.
出版: (2009)

Is iconic memory iconic?
由: Quilty-Dunn, J
出版: (2019)

Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer.
由: Nathan, P, et al.
出版: (2012)

Bevacizumab‐induced pulmonary cystic disease
由: Dakota McNierney, et al.
出版: (2024-03-01)

ICON8: A GCIG phase III randomised trial evaluating weekly dosedense chemotherapy integration in first- line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis
由: Clamp, A, et al.
出版: (2017)

BEVACIZUMAB IN COMBINATION WITH IRINOTECAN IN THE TREATMENT OF RECURRENT GLIOBLASTOMAS
由: D. R. Naskhletashvili, et al.
出版: (2015-04-01)

Bevacizumab in maintenance therapy for ovarian cancer patients
由: L. Yu. Vladimirova, et al.
出版: (2020-08-01)

PERSPECTIVES ON USE OF BEVACIZUMAB IN PATIENTS WITH NEUROENDOCRINE TUMORS. CASE REPORT
由: G. S. Emelianova, et al.
出版: (2017-12-01)

Systemic Bevacizumab for Severe Recurrent Respiratory Papillomatosis
由: Swetha Tatineni, et al.
出版: (2022-01-01)

Icon /
由: Forsyth, Frederick, 1938-
出版: (1996)

Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment
由: Clamp, A, et al.
出版: (2018)

Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer.
由: Zweifel, M, et al.
出版: (2011)

Icons and power: The Mother of God in byzantium
由: Parpulov, G
出版: (2008)

Iconic transition: alternatives and choices in education
由: Aleksandr A. Polonnikov
出版: (2022-05-01)

Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial
由: Blagden, S, et al.
出版: (2020)

Biomarkers to predict the clinical efficacy of bevacizumab in cancer.
由: Jubb, A, et al.
出版: (2010)

Treat-and-extend intravitreal bevacizumab for branch retinal vein occlusion
由: Rush, R, et al.
出版: (2014)

The Seventh Ecumenical Council and the veneration of icons in Orthodoxy
由: A. Nicolaides
出版: (2014-12-01)

Systemic bevacizumab for recurrent respiratory papillomatosis. A case series
由: Kristine Grubbe Gregersen, et al.
出版: (2023-12-01)

The influence of bevacizumab on platelet function
由: M Fehr, et al.
出版: (2011-07-01)

Shattered icon /
由: 455712 Napier, Bill
出版: (2003)

Iconic building /
由: 368816 Jencks, Charles
出版: (2005)

City icons /
由: Dunlop, Beth, 1947-, et al.
出版: (1999)

Forgery of Icons
由: Julia Spies
出版: (2009-04-01)

The Theology of the Icon
由: Aidan Hart
出版: (2024-08-01)

Perceptions of an Icon
由: Ksenija Pegaseva
出版: (2011-04-01)

Iconic Propositions
由: Jesse J. Fitts
出版: (2020-05-01)

Cultural Iconicity
由: Bent Sørensen, et al.
出版: (2015-06-01)

Icons of Transgression
由: Bent Sørensen
出版: (2011-12-01)

The Iconic Microphone
由: Jos Mulder
出版: (2015-06-01)

Hollywood Icons
由: Helle Kannik Haastrup
出版: (2015-06-01)

L. L. Bean : the making of an American icon /
由: 378152 Gorman, Leon A.
出版: (2006)

Bevacizumab (Avegra®) for the treatment of gynecological cancers: joint experience of several centers
由: A. G. Kedrova, et al.
出版: (2021-03-01)

Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study.
由: A M E Schauwvlieghe, et al.
出版: (2016-01-01)

Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma
由: D. Graceffa, et al.
出版: (2012-01-01)

Atezolizumab and Bevacizumab in Therapy for Patients with Hepatocellular Carcinoma in Real Clinical Practice
由: G. A. Serebrennikov, et al.
出版: (2023-07-01)

A CLINICAL CASE OF APPLICATION OF «ICON-INFILTRANT» SYSTEM IN THERAPEUTIC DENTISTRY
由: N.M. Brailko, et al.
出版: (2021-08-01)